Screen‑and‑Treat Strategy for Helicobacter pylori Infection Reduces Gastric Cancer Mortality
Screen‑and‑Treat strategy for Helicobacter pylori infection reduces gastric cancer mortality
Large‑scale implementation of a population‑based H. pylori screen‑and‑treat programme can significantly reduce gastric cancer deaths and inform European health policy, potentially lowering the burden of a highly preventable cancer.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Precision medicine in gastric cancer
- Gastric cancer
- DESTINY‑Gastric05 Phase 3 Trial of ENHERTU Initiated in Patients with Previously Untreated HER2 Positive Advanced Gastric Cancer
- Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
- Nivolumab/Chemo Yields Long-Term Survival in Advanced Gastric Cancers